International Journal of Otorhinolaryngology and Head and Neck Surgery

Jyoti D et al. Int J Otorhinolaryngol Head Neck Surg. 2019 Sep;5(5):1161-1166

http://www.ijorl.com

pISSN 2454-5929 | eISSN 2454-5937

Clinical profile of the patients presenting with laryngeal and hypopharyngeal carcinoma: an institution based retrospective study

Deep Jyoti*, Arti, Kunzes, Padam Singh Jamwal


Department of ENT, GMC, Jammu, Jammu and Kashmir, India

Received: 17 June 2019

Accepted: 04 July 2019

*Correspondence:

Dr. Deep Jyoti,

E-mail: deepjyotimanhas82@gmail.com

Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

ABSTRACT

Background: In India the overall incidence of cancer is low. However the cancers of head and neck have high incidence like that of larynx and pharynx.

Methods: This is a retrospective study conducted in the department of ENT, SMGS Hospital, GMC Jammu, for a period of 3 years from June 2016 to March 2019. 112 patients with cancer of larynx and hypopharynx were included in the study.

Results: The male to female ratio in the present study was 9:1. Mean age of presentation of the patients was 57.9±4.6 years. Hoarseness was the overall the most common complaint of the patients presenting with malignancy of larynx and hypopharynx (80.35%), followed by the complaint of dysphagia (68.7%). Smoking and alcohol consumption was the most common risk factor associated. 78 (69.6%) had primary malignancy of larynx and 34 (30.4%) had primary malignancy arising from hypopharynx. Most common site of presentation for laryngeal cancer was supraglottis (56/78) while pyriform sinus was the most common site to be involved in hypopharynx (24/34). 76 out of 112 patients (67.8%) presented with neck nodes. 41% of the patients presented in stage III and 32.14% patients presented in stage IV malignancy.

Conclusions: Malignant laryngeal and hypopharyngeal cancers are presented in late stages when management options become limited and survival of the patients fall significantly. Awareness of the symptoms developing due to laryngeal and hypopharyngeal cancer is necessary so that people can recognize the developing cancers in earliest stages.

Keywords: Cancer, Larynx, Hypopharynx, Risk factors, Staging

INTRODUCTION

Malignancy or cancer is defined as a pathological disturbance of growth in which cells in the body proliferate so exponentially that it spread throughout the body. Unless successfully treated they eventually cost death of the host.1 Larynx and pharynx lie in close proximity to each other. Larynx is divided into three sites- supraglottis, glottis and subglottis. Hypopharynx is divided into posterior pharyngeal wall, pyriform sinuses and post cricoid area. Cancer of larynx constitute 11.3-26.85% of the head and neck malignancies while that of hypopharynx constitute 14.13% of the all head and malignancies.2-4 Squamous cell cancer constitutes 85-95% of all the malignant tumors of the larynx and hypopharynx. Other types include lymphoepithelioma, spindle cell ca, verrucous ca, adenocarcinoma, adenoid cystic ca, lymphoma, minor salivary gland tumors, esthesioneuroblastoma, sarcomas, melanomas, metastatic tumors.5,6 Development of carcinoma of larynx and hypopharynx has been strongly associated with exposure to carcinogenic substances. Smoking and alcohol consumption are two most important risk factors for the development of squamous cell carcinoma. Other risk factors include dietary deficiency, laryngopharyngeal reflux, occupational exposure to the carcinogenic substances. In developing countries, the incidence of malignant tumors is on rise for the reasons unknown. This may be connected to frequent exposure to inhaled carcinogenic substances, irritants and malnutrition.6,7 Patients of laryngeal and hypopharyngeal malignancy usually present with change in voice which may be due to malignancy arising from the vocal folds, infilteration of tumor into the paraglottic muscles, infilteration of recurrent laryngeal nerve. Other symptoms with which patients present are respiratory distress, dysphagia, cough, haemoptysis, neck swelling. In the developing countries, patients usually present in late stages (stage III and stage IV). Management of such patients becomes a difficult task. A combined multimodality treatment becomes necessary including radiotherapy, chemotherapy and surgery depending upon the stage of the tumor. In country like ours, major challenges for management of a patient are late presentation, acceptance of the treatment by the patient and family, poor nutritional status of the patient. The study was done in a tertiary hospital to present the clinico-pathological profile of the patients with laryngeal and hypopharyngeal tumors.

METHODS

This is a retrospective study conducted in the department of ENT, SMGS Hospital, GMC Jammu, for a period of 3 years from the hospital records available. All the patients with laryngeal and hypopharyngeal malignancy admitted in the hospital from June 2016 to March 2019 were included in the study.

Inclusion criteria

All the cases of laryngeal or hypopharygeal malignancy who were admitted in our hospital were taken up for the study.

Exclusion criteria

Non-malignant tumors reported on histopathology were excluded from our study. Those with recurrence after previous treatment were also excluded.

A total of 112 patients were included for the study. These included 34 patients of hypopharyngeal malignancy and 78 patients with laryngeal malignancy. Work up of the patients included a detailed history about the symptoms and their progression like change of voice, difficulty in breathing, pain in throat, cough, neck mass etc. Personal history regarding smoking, alcohol intake, tobacco chewing was recorded. A complete examination with special reference to the head and neck including indirect laryngoscopy, flexible laryngeal endoscopy and neck examination for secondary metastasis was done. Radiological investigation included chest X-ray, CECT of neck and MRI (whenever required). All the patients had under-went biopsy from the site of primary lesion and FNAC was performed in case where neck nodes were present. Clinical TNM staging was done as per American Joint Committee on Cancer (AJCC, 2002).9 All the findins were analysed using Microsoft excel and presented in number and percentages.

RESULTS

A total of 112 patients were included in the present study. 101 patients were male and 9 were female. The male to female ratio in the present study is 9:1. Mean age of presentation of the patients was 57.9±4.6 years with range of 25-90 years. Maximum patients in our study were in the age group of 51-60 years i.e. 31% (Table 1). Only 3 patients were below 30 years of age. In the present study 56% of the patients were from the rural areas and 77% of these patients were farmers by occupation followed by labourers (24%). Hoarseness was the overall the most common complaint of the patients presenting with malignancy of larynx and hypopharynx (80.35%) followed by the complaint of dysphagia (68.7%). However, patients of hypopharyngeal malignancy commonly presented with neck node/s (Table 2). 76.7% of the patients in our study were smokers either in the form of cigarette or bidi. Average period of smoking was 30 years. Most of the patients smoked ≥1 bundle/day. 49% of the patients consumed alcohol while 30.3% were both smoker and alcoholic as shown in Table 3.

Table 1: Age distribution of the patients.
Table reproduced from source PDF page 2

In the present study, 78 (69.6%) had primary malignancy of larynx and 34 (30.4%) had primary malignancy arising from hypopharynx. Table 3 shows the distribution of the patients based on the site of involvement of the primary tumor. Most common site of presentation for laryngeal cancer was supraglottis (56/78) while pyriform sinus was the most common site to be involved in hypopharynx (24/34).

All the patients in our study had squamous cell carcinoma as proved on histopathological examination the biopsy specimen. On larygoscopic examination, appearance of the growth varied from mucosa covered to ulceroproliferative type. On the basis of histopathological examination of the biopsy specimen from the primary site of tumors, they were classified as well differentiated, moderately differentiated and poorly differentiated carcinomas (Table 5).

Table 2: Presenting complaints of the patients with laryngeal and hypopharyngeal cancer.
Table reproduced from source PDF page 3
Table 3: Common risk factors associated with laryngeal and hypopharyngeal cancer.
Table reproduced from source PDF page 3
Table 4: Distribution of patients depending upon the site of origin of the tumor.
Table reproduced from source PDF page 3
Table 5: Histological grades of differentiation of squamous cell carcinoma.
Table reproduced from source PDF page 3
Table 6: T staging of the tumors.
Table reproduced from source PDF page 3

Seventy six out of 112 patients (67.8%) presented with neck nodes which were confirmed to be metastatic squamaous cell carcinoma on fine needle aspiration cytology (FNAC). Nodal metastasis was seen in 48 out 78 (61.5%) patients of carcinoma larynx and 28 out of 34 (82.35%) patients of carcinoma pharynx. Nodal status of the patients has been shown in the Table 6.

Table 7: Distribution of the patients according to the N nodal status.
Table reproduced from source PDF page 4
Table 8: Staging of the cancer.
Table reproduced from source PDF page 4

The present study showed that 41% of the patients presented in stage III and 32.14% patients presented in stage IV malignancy. Only 6 (5.35%) patients presented at stage I (Table 7).

Treatment modality

All the patients were subjected to either radical/curative treatment or palliative treatment. Surgery was primary modality of treatment in 12 patients. Total laryngectomy was done in these patients followed by radiotherapy. Radiotherapy or radiotherapy combined with chemotherapy was the mode of treatment in majority of the patients. External beam radiation therapy with cobalt 60 was used for radiation in 5 day a week regimen. A total of 65-70 Gy was given over a period of 6-7 weeks in 33-35 fractions. Cisplatin, 5- fluorouracil, carboplatin, paclitaxel were the commonly used drugs for the chemotherapy.

DISCUSSION

Incidence of cancer as such is low in India. However cancer of some parts of the body like pharynx and larynx has high incidence.2 Malignancy of larynx is more common in males. In hypopharynx too males have high incidence of malignancies except the postcricoid region where it is more common in females. Male to female ratio was 9:1. Most of the patients presented in 6th and 7th decade. This is in agreement with other studies done in the past. Ogura et al reported male to female ratio of 7:1 and most of the patients presenting in 6th decade of life for malignancy of larynx and laryngopharynx.10 Kim et al (2003) reported 6th and 7th decade as most common age of presentation during a survey of head and cancers in Korea.11

Most common overall symptom for which patients came to us was hoarseness (80.35%). Hoarseness is the first feature to develop in glottis carcinoma as slight change of voice lead to change in character of voice. In other subsites also growing tumor causes change in various characters of voice leading hoarseness to commonest presenting feature for which patient consults doctors. Dysphagia is the most common presenting feature in hypopharyngeal carcinoma in our study (21/34) and also reported similarly in other studies.12,13 Dysphagia is also common in advanced stages of laryngeal carcinoma. Patients tend to ignore hoarseness and dysphagia initially. They usually visit local pharmacist or chemist and take medication for symptomatic relief. Even if they visit a doctor who is not expert in laryngology, these patients face a significant delay in getting a referral to an otolarygologist.

76.7% of the patients in our study were smokers while 49% were alcoholic. This indicates that smoking is the lone risk factor responsible for the development of laryngeal and hypopharyngeal carcinoma followed by alcohol. Alcohol and smoking play synergistic role in development of malignancy. Zonungsangi et al found 96.6% patients with hypopharyngeal tumors as chronic smokers.1 Verma et al reported 79.59% patients presenting with cancers of larynx and laryngopharynx (hypopharynx) as smokers.14 Substance benzopyrene found in cigarette smoke might be the responsible factor.15

Supraglottis was the commonest site of development of laryngeal carcinoma i.e. 56 out of 78 patients of laryngeal malignancy had supraglottic origin. Supraglottis was also reported to be the commonest site for ca larynx in previous studies.14,16 Ogura et al reported glottis as the common site (50-60%) and Fasunla et al reported tranglottic as the most common site of presentation in laryngeal carcinoma.6,10 Glottis carcinoma is reported as common laryngeal cancer in western literature while in Indian studies supraglottis remain the commonest site. Glottic cancer produces symptoms like hoarseness in very early stages. In developing countries most of these symptoms tend to be ignored by the patients or either they are being treated as laryngitis. Another reason of supraglottic being common in our country might be the smoking, tobacco chewing and alchohol consumption supra-added with poor nutrition. Commonest site of origin in hypopharyngeal malignancy was pyriform fossa i.e. 20 out of 34 (17.8%) followed by posterior pharyngeal wall. Saleh et al and Zonunsangi et al also reported the pyriform sinus as the common site in hypopharyngeal malignancy.1,17 There seems to be changing trends in presentation of hypopharygeal malignancy in previous studies. Verma et al reported post cricoid region as most common site in hypopharynx while Zonungsangi et al found that in all the patients with hypopharyngeal malignancy had primary site of origin from pyriform sinus.1,14

Most of the patients had moderately differentiated carcinomas i.e. in 59/112 (52.67%). As per AJCC (2002), T staging was done in all the patients. In patients with laryngeal malignancy, most of the patients had T2 (35/78) or T3 (24/78) tumor stage. In hypopharynx most of the patients had tumor stage of T2 (12/34).

Nodal metastasis occurs with different frequencies in different subsites. Supraglottic cancer metastasizes early as compared to that of glottis. Nodal metastasis is rare in glottic carcinoma owing to its non lymphatic anatomic formation. In hypopharynx primary malignanacy has propensity to metastasis and bilateral metastasis is more common as posterior pharyngeal wall and postcricoid area are the midline structures. Nodal metastasis was seen in 76 out of 112 patients in our study with frequency in order of N1 (37.5%)> N2 (29.68%)> N3 (3.5%).

In the present study, most of the patients presented in III and IV stage i.e. 41% and 32.14% respectively. 21.4% patients presented in stage II and 5.35% presented as stage I. The results are comparable to results reported by Kukreja et al also observed maximum cases in stage III (29.8%) and IV (45.8%).12

CONCLUSION

Hereby the conclusion drawn from the present study is that the laryngeal and hypopharyngeal malignancy is more common in males owing to more prevalence of addictions in males compared to females. Incidence of malignancy increases with increasing age. Most common presenting symptoms are hoarseness and dysphagia. Most of the patients present in stage III and stage IV which shows the lack of awareness in common masses and lack of availabily of medical help in proximity. Commonest site is supraglottis in larynx and pyriform sinuses is the commonest site of presentation in cancers of hypopharynx.

Funding: No funding sources

Conflict of interest: None declared

Ethical approval: Not required

REFERENCES

  1. 1. Zonunsangi, Sobita P, Sudhiranjan T, Malik P, Tenzing JB, Konyak SY. Etiopathological Factor, Clinical Presentation and Management of Hypopharyngeal Malignancies. Indian Med Gazette. 2014; 271-275.
  2. 2. Bhattacharjee A, Chakraborty A, Purkaystha P. Prevalence of head and neck cancers in the north-east- an institutional study. Indian J Otolaryngol Head Neck Surg. 2006;58:15-9.
  3. 3. Manjari M, Popli R, Paul S, Gupta VP, Kaholon SK. Prevalance of oral cavity, pharynx, larynx and nasal cavity malignancies in Amritsar, Punjab. Indian J Otolaryngol Head Neck Surg. 1996;48:189-96.
  4. 4. Thakur S, Chaturvedi V, Singh AK, Puttewar MP, Raizada RM. Pattern of nose, pharynx, larynx and oesophagus(ENPLO) cancers in rural based hospital. Indian J Otolaryngol Head Neck Surg. 2001;53(2):93-9.
  5. 5. Mohant BK, Bahadur S, Lal P, Gairola M, Rath GK. Cancer of head and neck. In: Rath GK, Mohanti BK. editors. Textbook of radiation oncology, principles and practice. 2nd edition. New Delhi: Elsevier; 2004: 131-199.
  6. 6. Fasunla AJ, Ogundoyin OA, Onakoya PA, Nwaorgu OG. Malignant tumors of the larynx: Clinicopathological profile and implication for late disease presentation. Niger Med J. 2016;57(5):280-5.
  7. 7. Wright R, Paleri V, Arullendran P. Current theories for the development of non-smoking and nondrinking laryngeal carcinoma Curr Opin Otolaryngol Head Neck Surg. 2003;11:73-7.
  8. 8. Boeing H, Dietrich T, Hoffman K, Pischon T, Ferrari P, Lahmann PH, et al. intake of fruits and vegetables and risk of fruits and vegetables and risk of cancer of the upper aerodigestive tract: The prospective EPIC- study. Cancer Causes Control. 2006;957-69.
  9. 9. Greene F, Page DL, Flemming ID, Fritz AG, Balch CM, Haller DG (eds). The AJCC cancer staging manual, 6th ed. Springer, New York, 2002.
  10. 10. Ogura JH, Spector GJ. The Larynx:In Nelson TF (ed);Management of the patient with Cancer; Chapter 13. Philadelphia: WB Saunders Company; 1976: 206-238.
  11. 11. Kim MK, Kim YM, Shim YS, Kim KH, Chang HS, Choi JO, et al. Epidemiologic survey of head and neck cancers in Korea. J Korean Med Sci. 2003;18:80-7.
  12. 12. Kukereja A, Varshney S, Gupta N, Harsh M, Bist SS, Bhagat S. Clinical Profile of Pharyngeal Malignancy in a Tertiary Care Centre, State of Uttrakhand. Indian J Otolaryngol Head Neck Surg. 2013;65;53-8.
  13. 13. Bhagat S, Singh B, Verma SK, Singh D, Bal MS. Clinic-pathological study of tumors of hypopharynx. Indian J Otolaryngol Head Neck Surg. 2003;55(4);241-3.
  14. 14. Verma A, Mehta S, Panda NK, Mann BS, Mehra YN. Presentation of Carcinoma Larynx and Hypopharynx- An Analysis of 840 Cases. Indian J Otolaryngol. 1990;42:50-3.
  15. 15. Saxena S, Sonakhya N, Mishra P, Yadav R, Bapna AS. Cervical node metastasis in carcinoma of pyriform sinus:a prospective analysis of prevalence and distribution. Indian J Otolaryngol Head Neck Surg. 2001;53(4):273-6.
  16. 16. Chadha S, Gupta B, Jatwani S, Gulati A. A study of patient factors and tumor characteristics in malignancy of larynx: A tertiary care centre experience. J Laryngol Voice. 2011;1:79-80.
  17. 17. Saleh EM, Abdullwahab AA, Kammal MM. Age and sex incidence of hypopharyngeal tumors in upper Egypt:assult university experience. J Laryngol Otol. 1995;109:737-40.